| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 263 |
| 1 | PEMBROLIZUMAB | 224 |
| 2 | IPILIMUMAB | 185 |
| 3 | RUXOLITINIB | 170 |
| 4 | DUPILUMAB | 154 |
| 5 | RIBOCICLIB | 145 |
| 6 | ADALIMUMAB | 108 |
| 7 | LETROZOLE | 77 |
| 8 | METHOTREXATE SODIUM | 74 |
| 9 | METHOTREXATE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GENTIAN VIOLET | 1 | 0.0192 |
| 1 | INTERLEUKIN-10 | 5 | 0.0139 |
| 2 | COLLOIDAL SILVER | 1 | 0.0116 |
| 3 | MOGAMULIZUMAB-KPKC | 13 | 0.0096 |
| 4 | NITISINONE | 9 | 0.0094 |
| 5 | METHOXSALEN | 1 | 0.0079 |
| 6 | NIVOLUMAB AND RELATLIMAB-RMBW | 4 | 0.0078 |
| 7 | TALIMOGENE LAHERPAREPVEC | 12 | 0.0076 |
| 8 | CEFACLOR | 11 | 0.0071 |
| 9 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 9 | 0.0109 |
| 1 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 2 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 3 | Lymphocyte Activation Gene-3 Blocker [EPC] | 4 | 0.0078 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 474 | 0.0048 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 186 | 0.0039 |
| 6 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 7 | Lymphocyte Growth Factor [EPC] | 4 | 0.0032 |
| 8 | Antiseptic [EPC] | 12 | 0.0027 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 43 | 0.0022 |